These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3131862)

  • 1. Advances of immunotherapy of cancer: monoclonal antibodies and interferon.
    Foon KA
    Semin Oncol Nurs; 1988 May; 4(2):112-9. PubMed ID: 3131862
    [No Abstract]   [Full Text] [Related]  

  • 2. Biologicals and biological response modifiers: new approaches to cancer treatment.
    Oldham RK
    Cancer Invest; 1985; 3(1):53-70. PubMed ID: 3918773
    [No Abstract]   [Full Text] [Related]  

  • 3. Biological therapy of cancer.
    Foon KA
    Breast Cancer Res Treat; 1986; 7(1):5-14. PubMed ID: 3516264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapy: the old and the new.
    Oldham RK; Smalley RV
    J Biol Response Mod; 1983; 2(1):1-37. PubMed ID: 6196449
    [No Abstract]   [Full Text] [Related]  

  • 5. How interferons fight disease.
    Johnson HM; Bazer FW; Szente BE; Jarpe MA
    Sci Am; 1994 May; 270(5):68-75. PubMed ID: 8197446
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferons: not just alpha.
    Krown SE
    Cancer Treat Rep; 1986 Dec; 70(12):1353-5. PubMed ID: 2431773
    [No Abstract]   [Full Text] [Related]  

  • 7. The clinical implications of human interferon.
    Cesario TC
    Med Clin North Am; 1983 Sep; 67(5):1147-62. PubMed ID: 6413792
    [No Abstract]   [Full Text] [Related]  

  • 8. [The significance and outlook of cytokines in cancer therapy].
    Nihon Gan Chiryo Gakkai Shi; 1988 Apr; 23(4):907-15. PubMed ID: 3144574
    [No Abstract]   [Full Text] [Related]  

  • 9. [Interferon in the treatment of viral, neoplastic and immunologic diseases].
    Inglot AD
    Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic and clinical utility of gamma interferon.
    Ozer H
    Cancer Invest; 1990; 8(2):309-10. PubMed ID: 2119247
    [No Abstract]   [Full Text] [Related]  

  • 11. Interferon: antitumor actions.
    Fleischmann WR; Klimpel GR; Tyring SK; Baron S
    Transplant Proc; 1984 Apr; 16(2):516-23. PubMed ID: 6202028
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological monitoring and clinical trials of biological response modifiers.
    Urba WJ; Baseler MW
    Cancer Chemother Biol Response Modif; 1990; 11():281-302. PubMed ID: 2121208
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiviral treatment of chronic active hepatitis B. Combination therapy with beta interferon and recombinant gamma interferon].
    Eisenburg J; Caselmann W; Eder M; Pape GR
    Fortschr Med; 1988 Jul; 106(21):431-7. PubMed ID: 3146536
    [No Abstract]   [Full Text] [Related]  

  • 14. [Interferon in the treatment of hairy cell leukemia].
    Deptała A
    Acta Haematol Pol; 1989; 20(1):86-92. PubMed ID: 2515708
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon.
    Hood LE
    Am J Nurs; 1987 Apr; 87(4):459-65. PubMed ID: 2436479
    [No Abstract]   [Full Text] [Related]  

  • 16. Lymphokines, monoclonal antibodies, and other biological response modifiers in the treatment of cancer.
    Oldham RK; Thurman GB; Talmadge JE; Stevenson HC; Foon KA
    Cancer; 1984 Dec; 54(11 Suppl):2795-806. PubMed ID: 6437660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The antineoplastic effect of interferon].
    Olesen BK; Ernst P
    Ugeskr Laeger; 1986 Feb; 148(7):375-7. PubMed ID: 2420053
    [No Abstract]   [Full Text] [Related]  

  • 18. [Comparative study on the cytotoxic effects, on various human tumor cell lines, of recombinant human TNF and IFN (alpha, beta, gamma)].
    Ogawara M; Sone S; Utsugi T; Nakanishi M; Ogura T
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):741-3. PubMed ID: 3103543
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of multiple sclerosis with various interferons: the cons.
    Johnson KP
    Neurology; 1988 Jul; 38(7 Suppl 2):62-5. PubMed ID: 3133576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferons: current status and future directions of this prototypic biological.
    Smalley RV; Borden EC
    Springer Semin Immunopathol; 1986; 9(1):73-83. PubMed ID: 2425443
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.